Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
BIOGEM Research Institute, Ariano Irpino, Italy,
Kidney Blood Press Res. 2019;44(5):915-927. doi: 10.1159/000502648. Epub 2019 Aug 22.
Diuretic resistance is among the most challenging problems that the cardio-nephrologist must address in daily clinical practice, with a considerable burden on hospital admissions and health care costs. Indeed, loop diuretics are the first-line therapy to overcome fluid overload in heart failure patients. The pathophysiological mechanisms of fluid and sodium retention are complex and depend on several neuro-hormonal signals mainly acting on sodium reabsorption along the renal tubule. Consequently, doses and administration modalities of diuretics must be carefully tailored to patients in order to overcome under- or overtreatment. The frequent and tricky development of diuretic resistance depends in part on post-diuretic sodium retention, reduced tubular secretion of the drug, and reduced sodium/chloride sensing. Sodium and chloride depletions have been recently shown to be major factors mediating these processes. Aquaretics and high-saline infusions have been recently suggested in cases of hyponatremic conditions. This review discusses the limitations and strengths of these approaches.
Long-term diuretic use may lead to diuretic resistance in cardio-renal syndromes. To overcome this complication intravenous administration of loop diuretics and a combination of different diuretic classes have been proposed. In the presence of hyponatremia, high-saline solutions in addition to loop diuretics might be beneficial, whereas aquaretics require caution to avoid overcorrection. Key Messages: Diuretic resistance is a central theme for cardio-renal syndromes. Hyponatremia and hypochloremia may be part of the mechanisms for diuretic resistance. Aquaretics and high-saline solutions have been proposed as possible new therapeutic solutions.
利尿剂抵抗是心内科-肾内科医生在日常临床实践中必须解决的最具挑战性的问题之一,这给住院和医疗保健费用带来了相当大的负担。事实上,袢利尿剂是治疗心力衰竭患者液体超负荷的一线药物。液体和钠潴留的病理生理机制复杂,取决于几种主要作用于肾小管钠重吸收的神经激素信号。因此,为了克服治疗不足或过度,必须根据患者的情况仔细调整利尿剂的剂量和给药方式。利尿剂抵抗的频繁出现和棘手之处部分取决于利尿剂后钠潴留、药物肾小管分泌减少以及钠/氯感知减少。最近的研究表明,钠和氯的耗竭是介导这些过程的主要因素。最近建议在低钠血症的情况下使用 aquaretics 和高渗盐水输注。这篇综述讨论了这些方法的局限性和优势。
长期使用利尿剂可能导致心肾综合征中的利尿剂抵抗。为了克服这一并发症,已经提出了静脉内给予袢利尿剂和联合使用不同类别的利尿剂。在存在低钠血症的情况下,除了袢利尿剂外,高渗溶液可能是有益的,而 aquaretics 需要谨慎使用,以避免过度纠正。关键信息:利尿剂抵抗是心肾综合征的一个核心主题。低钠血症和低氯血症可能是利尿剂抵抗机制的一部分。 aquaretics 和高渗溶液已被提议作为可能的新治疗方案。